1Suppliers
0Customers
1Debt Items
3Related Chains
Bright Minds Biosciences Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| UIC |
UIC |
92%
|
Pursuant to the terms and conditions of the Exclusive License Agreement, UIC granted the Company an exclusive license to the Inventions |
Bright Minds Biosciences Inc. Customers
No clients on recordNo downstream customers found in our database for Bright Minds Biosciences Inc..
Bright Minds Biosciences Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| DRUG-DEBT |
Debt stack $76,296 |
90%
|
Market cache reports total debt of $76,296. |
Bright Minds Biosciences Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bright Minds Biosciences Inc..
Bright Minds Biosciences Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| DRUG-OWNER-JANUS-HENDERSON-GROUP-PLC |
JANUS HENDERSON GROUP PLC |
90%
|
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 93 tracked holders. |
Bright Minds Biosciences Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
100.00 |
2 |
|
| SCLX |
Scilex Holding Company |
100.00 |
2 |
|
| AARD |
Aardvark Therapeutics, Inc. |
36.29 |
1 |
['spend'] |
